Clinical Trial Update: CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update studying immunity and microbiome effects at intestinal and systemic sites in adults vaccinated with Ty21a for typhoid vaccinatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Ty21a vaccine (Ty21a vaccine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Typhoid Vaccination | Phase 4 | Status: ACTIVE_NOT_RECRUITING